Get started
222

HIGHTIDE THERAPEUTICS INC.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

2511 chart


Full chart

Key stats


Market capitalization
‪633.17 M‬ HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.32 HKD
Net income (FY)
‪−1.04 B‬ HKD
Revenue (FY)
0.00 HKD
Shares float
‪271.51 M‬
Beta (1Y)
1.43

Employees


Employees (FY)
66
Change (1Y)
−2 −2.94%
Revenue / Employee (1Y)
0.00 HKD
Net income / Employee (1Y)
‪−2.01 M‬ HKD

About HIGHTIDE THERAPEUTICS INC.


Sector
Health Technology
CEO
Li Ping Liu
Headquarters
Shenzhen
Website
hightidetx.com
Founded
2011
FIGI
BBG01KK3SJW8
Hightide Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for people suffering from non-viral chronic liver diseases, gastrointestinal diseases, and metabolic disorders with large and unsatisfied market needs. The company was founded by Li Ping Liu in 2011 and is headquartered in Shenzhen, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

2511 news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 2511 is 1.15 HKD — it has decreased by −2.38% in the past 24 hours. Watch HIGHTIDE THERAPEUTICS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange HIGHTIDE THERAPEUTICS INC. stocks are traded under the ticker 2511.
2511 stock has risen by 1.65% compared to the previous week, the month change is a −16.89% fall, over the last year HIGHTIDE THERAPEUTICS INC. has showed a −90.35% decrease.
2511 reached its all-time high on Jan 2, 2024 with the price of 13.18 HKD, and its all-time low was 0.72 HKD and was reached on Sep 10, 2024. View more price dynamics on 2511 chart.
See other stocks reaching their highest and lowest prices.
2511 stock is 14.95% volatile and has beta coefficient of 1.43. Track HIGHTIDE THERAPEUTICS INC. stock price on the chart and check out the list of the most volatile stocks — is HIGHTIDE THERAPEUTICS INC. there?
Today HIGHTIDE THERAPEUTICS INC. has the market capitalization of ‪633.17 M‬, it has increased by 5.36% over the last week.
Yes, you can track HIGHTIDE THERAPEUTICS INC. financials in yearly and quarterly reports right on TradingView.
2511 net income for the last half-year is ‪−228.59 M‬ HKD, while the previous report showed ‪−420.86 M‬ HKD of net income which accounts for 45.69% change. Track more HIGHTIDE THERAPEUTICS INC. financial stats to get the full picture.
No, 2511 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 11, 2024, the company has 66.00 employees. See our rating of the largest employees — is HIGHTIDE THERAPEUTICS INC. on this list?
Like other stocks, 2511 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIGHTIDE THERAPEUTICS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HIGHTIDE THERAPEUTICS INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HIGHTIDE THERAPEUTICS INC. stock shows the buy signal. See more of HIGHTIDE THERAPEUTICS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.